Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
American Journal of Respiratory Cell and Molecular Biology
|
December 16, 2003
Epithelial-mesenchymal interactions are linked to neovascularization
Margaret A Schwarz, ZeSheng Wan, Jie Liu, et al.
Journal of the National Cancer Institute
|
April 10, 2008
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation
Min H Kang, Zesheng Wan, Yun Hee Kang, et al.
Journal of the National Cancer Institute
|
July 12, 2007
Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide
Nino Keshelava, Elai Davicioni, Zesheng Wan, et al.
Neoplasia (New York, N.Y.)
|
May 29, 2020
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas
Emad Darvishi, Katherine Slemmons, Zesheng Wan, et al.
Cells
|
June 21, 2020
Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging
Hsiao-Chuan Liu, Eun Ji Gang, Hye Na Kim, et al.
Cancer Immunology, Immunotherapy : CII
|
August 29, 2013
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1
Yibing Xu, Jianping Sun, Michael A Sheard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
Hung C Tran, Zesheng Wan, Michael A Sheard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2018
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma
Wesley E Barry, Jeremy R Jackson, Grace E Asuelime, et al.
Molecular Therapy Oncolytics
|
March 28, 2017
Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma
Margarita Gutova, Leanne Goldstein, Marianne Metz, et al.
Frontiers in Oncology
|
December 20, 2021
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
Yongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
American Journal of Respiratory Cell and Molecular Biology
|
December 16, 2003
Epithelial-mesenchymal interactions are linked to neovascularization
Margaret A Schwarz, ZeSheng Wan, Jie Liu, et al.
Journal of the National Cancer Institute
|
April 10, 2008
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation
Min H Kang, Zesheng Wan, Yun Hee Kang, et al.
Journal of the National Cancer Institute
|
July 12, 2007
Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide
Nino Keshelava, Elai Davicioni, Zesheng Wan, et al.
Neoplasia (New York, N.Y.)
|
May 29, 2020
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas
Emad Darvishi, Katherine Slemmons, Zesheng Wan, et al.
Cells
|
June 21, 2020
Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging
Hsiao-Chuan Liu, Eun Ji Gang, Hye Na Kim, et al.
Cancer Immunology, Immunotherapy : CII
|
August 29, 2013
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1
Yibing Xu, Jianping Sun, Michael A Sheard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
Hung C Tran, Zesheng Wan, Michael A Sheard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2018
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma
Wesley E Barry, Jeremy R Jackson, Grace E Asuelime, et al.
Molecular Therapy Oncolytics
|
March 28, 2017
Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma
Margarita Gutova, Leanne Goldstein, Marianne Metz, et al.
Frontiers in Oncology
|
December 20, 2021
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
Yongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Page
of 1